Cargando…
Asymptomatic Bacteriuria Escherichia coli Are Live Biotherapeutics for UTI
Urinary tract infections (UTI) account for approximately 8 million clinic visits annually with symptoms that include acute pelvic pain, dysuria, and irritative voiding. Empiric UTI management with antimicrobials is complicated by increasing antimicrobial resistance among uropathogens, but live bioth...
Autores principales: | Rudick, Charles N., Taylor, Aisha K., Yaggie, Ryan E., Schaeffer, Anthony J., Klumpp, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236008/ https://www.ncbi.nlm.nih.gov/pubmed/25405579 http://dx.doi.org/10.1371/journal.pone.0109321 |
Ejemplares similares
-
Evaluation of the Live Biotherapeutic Product, Asymptomatic Bacteriuria Escherichia coli 2‐12, in Healthy Dogs and Dogs with Clinical Recurrent UTI
por: Segev, G., et al.
Publicado: (2017) -
Asymptomatic bacteriuria in recurrent UTI – to treat or not to treat
por: Cai, Tommaso, et al.
Publicado: (2017) -
Asymptomatic Bacteriuria in Clinical Urological Practice: Preoperative Control of Bacteriuria and Management of Recurrent UTI
por: Cai, Tommaso, et al.
Publicado: (2016) -
Is it possible to extrapolate the rates of resistance of Escherichia coli from asymptomatic bacteriuria in pregnant women to those of E. coli in uncomplicated community-acquired UTI?
por: Asenjo, Alejandra, et al.
Publicado: (2019) -
TRPV1 and the MCP-1/CCR2 Axis Modulate Post-UTI Chronic Pain
por: Rosen, John M., et al.
Publicado: (2018)